{
  "description": "FDA-approved drug-disease pairs identified during validation. These should be added to ground truth to improve evaluation accuracy.",
  "last_updated": "2026-01-24",
  "pairs": [
    {
      "drug": "Pembrolizumab",
      "disease": "Triple-negative breast cancer",
      "fda_approval_year": 2020,
      "notes": "KEYNOTE-355 (metastatic), KEYNOTE-522 (early-stage)"
    },
    {
      "drug": "Pembrolizumab",
      "disease": "Breast cancer",
      "fda_approval_year": 2021,
      "notes": "High-risk early-stage TNBC"
    },
    {
      "drug": "Doxorubicin",
      "disease": "Breast cancer",
      "fda_approval_year": 1974,
      "notes": "Anthracycline chemotherapy, cornerstone treatment"
    },
    {
      "drug": "Methotrexate",
      "disease": "Breast cancer",
      "fda_approval_year": 1959,
      "notes": "Part of CMF regimen"
    },
    {
      "drug": "Natalizumab",
      "disease": "Multiple sclerosis",
      "fda_approval_year": 2004,
      "notes": "Tysabri, first mAb for MS"
    },
    {
      "drug": "Erlotinib",
      "disease": "Pancreatic cancer",
      "fda_approval_year": 2005,
      "notes": "Tarceva + gemcitabine"
    },
    {
      "drug": "Cetuximab",
      "disease": "Colorectal cancer",
      "fda_approval_year": 2004,
      "notes": "Erbitux, KRAS wild-type"
    },
    {
      "drug": "Oxaliplatin",
      "disease": "Colorectal cancer",
      "fda_approval_year": 2002,
      "notes": "FOLFOX regimen"
    },
    {
      "drug": "Bevacizumab",
      "disease": "Colorectal cancer",
      "fda_approval_year": 2004,
      "notes": "Avastin, anti-VEGF"
    },
    {
      "drug": "Trametinib",
      "disease": "Melanoma",
      "fda_approval_year": 2013,
      "notes": "Mekinist, BRAF V600E/K"
    },
    {
      "drug": "Prednisone",
      "disease": "Rheumatoid arthritis",
      "fda_approval_year": 2012,
      "notes": "RAYOS delayed-release"
    },
    {
      "drug": "Umeclidinium",
      "disease": "COPD",
      "fda_approval_year": 2014,
      "notes": "Incruse Ellipta, also in Trelegy"
    },
    {
      "drug": "Thiotepa",
      "disease": "Cancer",
      "fda_approval_year": 1959,
      "notes": "Alkylating agent, various cancers"
    }
  ],
  "mesh_mappings_to_add": [
    {"drug": "Pembrolizumab", "drugbank_id": "DB09037", "disease_mesh": "D001943"},
    {"drug": "Doxorubicin", "drugbank_id": "DB00997", "disease_mesh": "D001943"},
    {"drug": "Methotrexate", "drugbank_id": "DB00563", "disease_mesh": "D001943"},
    {"drug": "Natalizumab", "drugbank_id": "DB00108", "disease_mesh": "D009103"},
    {"drug": "Erlotinib", "drugbank_id": "DB00530", "disease_mesh": "D010190"},
    {"drug": "Cetuximab", "drugbank_id": "DB00002", "disease_mesh": "D015179"},
    {"drug": "Oxaliplatin", "drugbank_id": "DB00526", "disease_mesh": "D015179"},
    {"drug": "Bevacizumab", "drugbank_id": "DB00112", "disease_mesh": "D015179"},
    {"drug": "Trametinib", "drugbank_id": "DB08911", "disease_mesh": "D008545"},
    {"drug": "Umeclidinium", "drugbank_id": "DB09076", "disease_mesh": "D029424"}
  ]
}
